B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 1.924 NOK 0.42% Market Closed
Market Cap: 75.2m NOK

Wall Street
Price Targets

BGBIO Price Targets Summary
Bergenbio ASA

Wall Street analysts forecast BGBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BGBIO is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Lowest
Price Target
5.05 NOK
162% Upside
Average
Price Target
5.1 NOK
165% Upside
Highest
Price Target
5.25 NOK
173% Upside
Bergenbio ASA Competitors:
Price Targets
AMGN
Amgen Inc
18% Upside
NYKD
Nykode Therapeutics ASA
103% Upside
ALT
Altimmune Inc
290% Upside
2256
Abbisko Cayman Ltd
37% Upside
KALV
Kalvista Pharmaceuticals Inc
141% Upside
NVAX
Novavax Inc
134% Upside
FHTX
Foghorn Therapeutics Inc.
160% Upside
INCY
Incyte Corp
18% Upside

Revenue
Forecast

Revenue Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BGBIO's stock price target?
Price Target
5.1 NOK

According to Wall Street analysts, the average 1-year price target for BGBIO is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Back to Top